DAYTRANA (Methylphenidate Transdermal System [MTS]) to Characterize the Dermal Reactions for ADHD
This study is completed in the United States. It is testing DAYTRANA (Methylphenidate Transdermal System [MTS]) to Characterize the Dermal Reactions for ADHD.
ADHDDrugFrom 6 Years to 12 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Daytrana may be useful for children experiencing ADHD.
What would participation involve?
Participants may receive Daytrana, attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for children with ADHD. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateJanuary 2007
Recruitment status
Completed
Enrollment listed in the registry
309
Sponsor
Noven Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT00434213
Official title
A Phase IV, Multi-center, Open-label Study of DAYTRANA (Methylphenidate Transdermal System [MTS]) to Characterize the Dermal Reactions in Pediatric Patients Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD).
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00434213. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 29 sites
Scottsdale
Scottsdale, Arizona
Site status: Not listed — confirm with the team
Irvine
Irvine, California
Site status: Not listed — confirm with the team
San Marcos
San Marcos, California
Site status: Not listed — confirm with the team
Spring Valley
Spring Valley, California
Site status: Not listed — confirm with the team
Wildomar
Wildomar, California
Site status: Not listed — confirm with the team
Boulder
Boulder, Colorado
Site status: Not listed — confirm with the team
Gainesville
Gainesville, Florida
Site status: Not listed — confirm with the team
Miami
Miami, Florida
Site status: Not listed — confirm with the team
Winter Park
Winter Park, Florida
Site status: Not listed — confirm with the team
Libertyville
Libertyville, Illinois
Site status: Not listed — confirm with the team
Northbrook
Northbrook, Illinois
Site status: Not listed — confirm with the team
Overland Park
Overland Park, Kansas
Site status: Not listed — confirm with the team
Bardstown
Bardstown, Kentucky
Site status: Not listed — confirm with the team
Owensboro
Owensboro, Kentucky
Site status: Not listed — confirm with the team
Cambridge
Cambridge, Massachusetts
Site status: Not listed — confirm with the team
Kalamazoo
Kalamazoo, Michigan
Site status: Not listed — confirm with the team
Las Vegas
Las Vegas, Nevada
Site status: Not listed — confirm with the team
Toms River
Toms River, New Jersey
Site status: Not listed — confirm with the team
Rochester
Rochester, New York
Site status: Not listed — confirm with the team
Cleveland
Cleveland, Ohio
Site status: Not listed — confirm with the team
Columbus
Columbus, Ohio
Site status: Not listed — confirm with the team
Portland
Portland, Oregon
Site status: Not listed — confirm with the team
Salem
Salem, Oregon
Site status: Not listed — confirm with the team
Philadelphia
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Jackson
Jackson, Tennessee
Site status: Not listed — confirm with the team
Austin
Austin, Texas
Site status: Not listed — confirm with the team
Lubbock
Lubbock, Texas
Site status: Not listed — confirm with the team
San Antonio
San Antonio, Texas
Site status: Not listed — confirm with the team
Norfolk
Norfolk, Virginia
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Daytrana. Phase 4 studies usually happen after treatment approval, to monitor real-world use.
Who might this study be for?
This study may concern people with adhd; age range: From 6 Years to 12 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Noven Therapeutics, which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
